Safeguarding COVID-19 and cancer management: drug design and therapeutic approach

Recent clinical cohort studies have highlighted that there is a three-fold greater SARS-Cov-2 infection risk in cancer patients, and overall mortality in individuals with tumours is increased by 41% with respect to general COVID-19 patients. Thus, access to therapeutics and intensive care is comprom...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorat, Nanasaheb, Pricl, Sabrina, Parchur, Abdul K., Somvanshi, Sandeep B., Li, Qifei, Umrao, Sachin, Townley, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445946/
https://www.ncbi.nlm.nih.gov/pubmed/37645153
http://dx.doi.org/10.12688/openreseurope.13841.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445946/
https://www.ncbi.nlm.nih.gov/pubmed/37645153
http://dx.doi.org/10.12688/openreseurope.13841.1

Ejemplares similares